| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President | Chief Executive Officer
1 company
Novak Rodger is a President at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $31.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2021 | CRSP Crispr Therapeutics AG | President | Sell | 25,000 | $165.00 | $4,125,000.00 | -4.2% | -30.7% | -62.5% | |
| Jun 28, 2021 | CRSP Crispr Therapeutics AG | President | Sell | 25,000 | $156.55 | $3,913,750.00 | -4.0% | -22.7% | -58.3% | |
| Jun 21, 2021 | CRSP Crispr Therapeutics AG | President | Sell | 25,000 | $128.62 | $3,215,458.23 | -0.7% | -10.1% | -50.1% | |
| Nov 30, 2020 | CRSP Crispr Therapeutics AG | President | Sale+OE | 100,000 | $125.00 | $12,500,000.00 | -7.2% | - | - | |
| Oct 9, 2020 | CRSP Crispr Therapeutics AG | President | Sale+OE | 25,000 | $100.00 | $2,500,000.00 | -1.9% | - | - | |
| Sep 1, 2020 | CRSP Crispr Therapeutics AG | President | Sale+OE | 25,000 | $92.62 | $2,315,577.70 | -1.3% | - | - | |
| Aug 19, 2020 | CRSP Crispr Therapeutics AG | President | Sale+OE | 25,000 | $100.00 | $2,500,000.00 | -3.7% | - | - | |
| Jul 7, 2020 | CRSP Crispr Therapeutics AG | President | Sale+OE | 25,000 | $90.00 | $2,250,000.00 | -3.7% | - | - | |
| Jul 1, 2020 | CRSP Crispr Therapeutics AG | President | Sell | 50,000 | $80.00 | $4,000,000.00 | -7.2% | - | - | |
| Jun 23, 2020 | CRSP Crispr Therapeutics AG | President | Sell | 50,000 | $75.00 | $3,750,000.00 | -6.7% | - | - |